We introduce an intradural approach to spinal cord stimulation for the relief of intractable pain, and describe the biophysical rationale that underlies its design and performance requirements. The proposed device relies on wireless, inductive coupling between a pial surface implant and its epidural controller, and we present the results of benchtop experiments that demonstrate the ability to transmit and receive a frequency-modulated 1.6 MHz carrier signal between micro-coil antennae scaled to the % 1 cm dimensions of the implant, at power levels of about 5 mW. Plans for materials selection, microfabrication, and other aspects of future development are presented and discussed.
I. INTRODUCTION
In the United States, approximately 25% of all physician visits are driven by the need to treat severe pain, with lower back pain being the most common complaint. In general, however, neck pain, neuropathic pain (e.g., diabetic neuropathy and postherpetic neuralgia), amputation pain, chronic pancreatitis, and pain after spinal cord injury are all poorly managed, with treatment by opioids typically exhibiting inadequate pain relief, unacceptable tolerance, and many side effects.
Within this context, the use of spinal cord stimulation (SCS) to relieve intractable pain symptoms 1,2 originated in the 1960s along with emerging theories of the neural basis of pain perception and the pathophysiology of chronic pain disorders. 3 Human SCS studies were initiated based on the theory that by using electrical stimulation to artificially activate descending pathways within the dorsal column of the spinal cord, the processing of pain-related signals below the stimulation site could be attenuated or blocked. Although the specific neural mechanisms that underlie the clinical efficacy of this treatment remain poorly understood, there is now abundant clinical evidence that SCS is capable of providing sustained pain relief to select patients with intractable chronic pain. Unfortunately however, many patients are trialed and obtain no pain relief, and a high percentage of patients implanted with a SCS device experience only marginal improvement, or no improvement, in their pain symptoms. Treatment success rates of about 50% or less are reported frequently. [4] [5] [6] In general, electrical stimulation must evoke sensory perceptions in the painful area of the body in order for the treatment to be effective. To accomplish this, the region within the dorsal column of the spinal cord that contains axons that are functionally related to the painful body area must be activated. Therefore, effectiveness of SCS treatment is critically dependent on the capacity of the device to selectively activate targeted axons within a specific sub-region of the dorsal column without activating the nearby dorsal rootlets. To deliver such highly focused electrical stimuli safely and efficiently, each electrode contact should be positioned as close to the targeted axons as possible and the resulting volumetric pattern of tissue activation should conform tightly to the anatomy of the targeted neural pathway. Feirabend et al. 7 carried out a detailed morphometric analysis of the fibers in the dorsal columns that must be activated in order to obtain paresthesia effects in the relevant dermatomes at amplitudes that are below the discomfort threshold. While the stimulation amplitude rises steeply with depth of the fiber within the dorsal column, 8 they noted that there is an inverse relationship between the stimulation discomfort threshold of a particular fiber and the distance between it and the electrode. (The higher amplitudes needed to stimulate the deeper fibers would exceed the discomfort thresholds in the shallower tracts of fibers.) Therefore, for epidurally placed leads, they noted that an approximately 100 lm thick layer of fibers about 250 lm below the surface of the spinal cord represented the nominal stimulation target.
Moreover, because the existing SCS devices deliver electrical stimuli through electrodes placed outside of the fibrous outer lining of the spinal canal (dura), there can be inefficient and poorly localized patterns of spinal cord activation due to the electrical shunting effect of the cerebrospinal fluid that fills the space between the inside surface of the dural lining and the spinal cord. 9 These limitations can result in an inability to reliably and selectively activate targeted regions of the spinal cord, while inadvertently activating a)
Author to whom correspondence should be addressed. Electronic mail: matthew-howard @uiowa.edu. non-targeted regions, 10 and are thought to be important contributing factors to the significant incidence of sub-optimal or poor treatment outcomes that can arise with existing SCS devices. 11, 12 Despite these limitations large numbers of patients nevertheless choose to receive SCS. The size of the approximately $1B and rapidly growing SCS market attests to the large scope of this public health problem and the fact that under a number of circumstances, electrical activation of the spinal cord can provide pain relief for patients who have failed all other treatment modalities.
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In terms of the instrumentation, when SCS electrodes were first placed in human subjects, most were implanted on the surface of the dura, but in some instances the dura was opened and electrodes were placed directly on the pial surface of the spinal cord. [13] [14] [15] [16] The wires from electrodes placed directly on the spinal cord thus had to pass through the dura, resulting in a mechanical tether between the electrode and the dura. That, in turn, made the entire assembly sensitive to the relative motion of the spinal cord with respect to the dura, causing possible shifts in electrode position, the potential for CSF leaks, etc. Moreover, the electrodes were constructed of conventional materials, were bulky, and had a limited number of contacts through which stimuli could be delivered. All of this made the locations of the contacts relative to targeted and non-targeted neural structures difficult to control, since adjustments were not possible following the implantation surgery. Because of these factors, and the increased risks associated with opening the dura, there was no obvious therapeutic advantage to the intradural approach at the time, and the use of intradural stimulating electrodes was eventually discontinued. 15 At present, all SCS devices use extradural stimulating electrodes.
The clinical importance of the limited ability of extradural devices to selectively activate circumscribed regions of the spinal cord is reflected in the numerous efforts made by device manufacturers to mitigate this problem. These include the development of spatially distributed multi-contact extradural arrays and stimulation protocols that provide flexibility in the spatial topography of stimulation patterns delivered to the surface of the dural membrane. 17 This strategy allows the physician to adjust the anatomical location of maximal stimulation on the dural surface, however, CSF shunting of the electrical stimulus continues to markedly attenuate and spatially "blur" the stimulation effects at the level of the underlying spinal cord surface. Clinicians have also used a strategy of placing multiple cylindrical electrodes within the extradural space for the purpose of mechanically reducing the size of the CSF-filled space and displacing the electrode contacts to a position closer to the spinal cord. 18 A device modification recently introduced by one manufacturer of SCS devices 19 is specifically intended to address problems associated with movement of the spinal cord within the CSFfilled spinal canal that occurs when patients change position. These positional changes alter the spatial relationship between an extradural electrical source and the spinal cord target, resulting in shifts in the pattern of tissue activation. The new device senses patient position and automatically adjusts stimulus parameters for the purpose of achieving stable therapeutic effects. However, as with all other SCS design changes introduced to-date, the addition of a position sensor does not address the fundamental problems of CSF shunting of the electrical stimulus and the inability of extradural stimulating devices to efficiently and selectively activate circumscribed sub-regions of the spinal cord.
We are developing a new approach to SCS implementation which seeks to address these problems. As suggested in Fig. 1 , our "Iowa-Patch TM (I-Patch)" device consists of a soft, thin, instrumented band that is surgically placed directly on the spinal cord. Wireless transmission of power and stimulus signals from a separate control unit positioned epidural to the implant allow for electrical impulses to be delivered directly into spinal cord targets by an electrode array on the underside of the band, in contact with the surface of the spinal cord. The transmitted signals are decoded by a batteryfree, thin-film electronic circuit on the implant, which is able to function without the need for on-board memory or computational capability (all of which are resident within the transmitter package). This design is intended to overcome the shortcomings of the present SCS paradigm, by significantly reducing the stimulus power lost within the CSF, by creating sharply contoured current density topographies that are maximal within the targeted sub-regions of the spinal cord and minimal outside of these targeted areas, and by allowing for optimum performance independent of the patient's orientation and movement.
In what follows, we present the biophysical design criteria for this device, and provide an overview of the experimental studies done to date in support of the feasibility of our approach. We put particular focus on the nature of the on-board electronics, and provide the first results of the relevant power and signal transfer studies that were done on a bench-top realization of the essential analog front-end of the control circuit. We then discuss the path forward toward the synthesis of a full prototype device suitable for use in an in vivo clinical trial, and close with a description of our plans for carrying out that work.
II. BIOPHYSICAL DESIGN CRITERIA

A. Medical considerations
The basic surgical procedure (laminectomy and mid-line durotomy) that will be used to expose the spinal cord for implantation of the I-Patch is well established and safe. When performed by skilled practitioners, the risk of CSF fistula formation is anticipated to be minimal and in theory the overall complication rate of an I-Patch implantation procedure should not differ significantly from complication rates associated with current surgical procedures used to implant extradural electrode arrays. Of course, any spinal surgical procedure carries with it significant risk. As is the case with current SCS surgery, the patients selected for the I-Patch procedure will have failed a comprehensive trial of conservative, non-surgical pain management. Barring infectious complications, in almost all cases the I-Patch device will be a permanent implant. These clinical considerations dictate the main features of the implant's design and the system's mode of operation. First, there must be minimal potential for CSF leaks and concomitant risk of wound break down and infection, meaning that there must be wireless coupling between the epidural transmitter/controller and the intradural implant. Second, the device must remain stably in place on the surface of the spinal cord when the patient moves. (The relative motion between the spinal cord and the surrounding dura during movement by the patient must not cause the implant to shift its position on the surface of the spinal cord.) This means that it must be appropriately fixed to the pial surface. Third, in spite of the requirement for fixation, there must be a thin gap between the underside of the (biocompatible) implant and the surface of the spinal cord, except for the points of contact by the individual electrodes. This gap facilitates a firm mechanical fixation of the slightly protruding electrode contacts with the pial surface, and provides a space into which the spinal cord may expand and contract slightly with the cardiac cycle and respiratory movements. Lastly, there must be minimal heat dissipation by the implant's onboard circuitry, to avoid any injuries to the adjacent tissues. It is also possible that the dorsal root entry zone nociceptors and neuroaxons within certain tracts could be activated by heat; see, for example, Pehl et al. 20 From these considerations, several basic design parameters for the device can be established. For instance, the low power-dissipation requirement implies that as much of the overall system's functional circuitry as possible, including its memory and microprocessor(s), be housed in the epidural transmitter/control unit, while the spinal cord implant has only the receiver, power transducer, pulse decoder, and electrode drivers on board. The ability to accommodate relative motion between the spinal cord and dura requires a robust wireless coupling between the transmitter and receiver so that signal strength is not lost when the antenna of one is displaced relative to that of the other during a patient's normal physiological movements. The requirement for positional stability of the implant on the spinal cord surface is achieved using two mechanisms. The I-Patch electrode band exerts a uniform, gentle inward circumferential pressure on the spinal cord that produces the desired mechanical contact between the electrodes and the spinal cord while also preventing dislodgment of the band away from spinal cord (Fig. 1) . A pial suture is also placed through the device to prevent rotational movement of the band. This suturing technique is used routinely to secure syrinx-to-subarachnoid shunt tubing implanted in patients with a spinal cord syrinx. More detailed device design considerations are discussed in the remainder of this section, and the results of our preliminary feasibility tests follow in Sec. III.
B. Electrical considerations
In the large dorsal column pathways activation of large numbers of axons that are located greater than 0.5 mm below the pial surface will likely result in broader somatotopic coverage of painful areas of the body and an increased probability of achieving effective pain relief. Extrapolating from the results of earlier spinal cord lesioning studies, activation of axons within deeply positioned dorsal midline structures may result in complete relief of visceral pain. Pathways positioned within the lateral and anterior regions of the spinal cord are not activated by current SCS devices. There are many potential stimulation targets in these regions, including the lateral and anterior spinothalamic tracts, which conduct pain and temperature signals to the brain. In attempts to activate these pathways, SCS systems typically generate pulse trains at low frequencies, e.g., 20 to 100 Hz, at pulse widths on the order of 100 ls, corresponding to a low-end duty cycle of 0.2%. The pulse heights are up to 10 V, although larger fiber tracts have lower stimulation thresholds, and the paresthesia effect (a numbing of the pain sensation) most typically occurs at amplitudes of 2 to 4 V. The electrophysiological considerations underlying SCS design are largely driven by the tissue resistivities, which vary widely among the relevant tissues (approximately 60 X cm for CSF and 2500 X cm for epidural fat) and are very anisotropic as well (approximately 167 X cm for longitudinal tracts of white matter, and almost 18 times higher transversely). 21 The I-Patch design is aimed at optimizing the therapeutic benefit to the patient by maximizing the SCS current densities in the targeted conducting tracts of the spinal cord itself, while minimizing the current density shunted away by the CSF.
Enablement of this approach will likely require the electrodes to be placed on the surface of the spinal cord in the manner shown in Fig. 2 . The stand-off column between the exposed portion of the electrode and the underside of the implant is meant to lift the implant off the surface of the spinal cord by about 100 lm, in order to accommodate micropulsations of the spinal cord, as described above. By insulating the surface of the stand-off, it is possible to minimize the shunting effect of the CSF, as the exposed portion of the electrode will be in contact only with the pial surface of the spinal cord, and not with the CSF itself.
C. Mechanical considerations
The structural characteristics of the implant are governed by the dimensions and properties of the spinal cord and canal, the dynamics of the cord's motions and pulsations, and the physical, electrical and electromagnetic requirements of the on-board electronics. As suggested in Fig. 1(a) , the spinal cord is slightly oblong in cross section, with location-dependent sagittal diameters of about 6-8 mm and characteristic transverse diameters of about 10 mm, with both measures of diameter generally decreasing from the cervical toward the sacral regions. 22 In what follows, we will use 6 and 10 mm as typical values of sagittal and transverse diameters, respectively. A characteristic value of the mean diameter of the normal spinal canal has been measured to be approximately 14.5 mm, 23 hence there is about 2-3 mm of CSF resident between the spinal cord's surface and the inside of the dura. (The spinal canal also contains epidural fat.) The CSF circulates within that gap and that flow must not be impeded by the presence of the implant. Therefore, as suggested in Fig. 2 , the target thickness of our device is no greater than 500 lm, including the height of the electrode.
As mentioned above, the spinal cord moves within the canal during flexion/extension movements of the head, bending of the trunk, etc. Ried 24 found gross movements of the spinal cord of 5 to 8 mm at the T5 level during flexion and extension of the head and neck, with larger values (1.0 to 1.8 cm) at higher levels of the spine. More recently, Figley and Stroman 25 found that even for quiescent individuals, there were direction-dependent, background movements of the spinal cord of between 0.1 to 0.7 mm associated with the heartbeat. The presence of such motions means that the implant will also be moving. As a consequence, the coupling strength of the wireless connection between the transmitter and receiver units may then vary with those motions. Since there could nominally be ranges of 1 to 3 mm of axial separation and perhaps up to 10 mm of lateral separation between the centerlines of the respective coils on the transmitter and receiver units, the coil radii must be scaled so that the signal strength will always stay well above the operational threshold. Lastly, as mentioned briefly above, there is also a small diametric pulsation (a "breathing mode") of the spinal cord itself. Observations of this low-amplitude phenomenon have been made by Mügge et al., 26 and the existing quantitative measurements 27 (canines) suggest that the cyclical change in mean radius, Dr, is on the order of 100 lm, i.e., a fractional change of Dr/r % 1% at the heart rate of the patient. The implant, which is fitted circumferentially around the spinal cord, must not constrict this continuous (roughly 1 Hz) motion, and hence must be very flexible yet able to remain securely in place. See Sec. IV B 1 for some further discussion on this point.
Importantly, the implant material must also be biocompatible with the spinal cord tissues and the CSF, be stable against temporal degradation, be a suitable substrate for the thin-film electronic circuit that will reside on it, and have satisfactory heat transfer characteristics. A recent review by Hassler et al. 28 of polymers used in neural implants describes a number of candidate materials that would be suitable for this purpose, including polyimide, parylene and polydimethylsiloxane (PDMS). For the electrodes, a platinum-iridium alloy will likely be the material of choice.
The presently envisioned configuration, Fig. 3 , seeks to meet these requirements. The main body of the implant would be approximately 6 mm wide by 15 mm long, with each of the flexible side arms being approximately 6 mm in length. The entire implant would have a pre-formed curvature approximating that of the spinal cord, and it would be fitted onto it in a saddle-like arrangement. The undulations in the side arms would provide for the circumferential expansion and contraction needed during the spinal cord's pulsation cycles. The epidural control unit ( Fig. 1(a) ) would be positioned such that its on-board transmitter coil was centered over the receiver coil on the implant. The transmitter coil is sized such that the coupling strength would always be adequate independent of the implant's displacement during relative movement caused by the motion of the spinal cord.
D. Communications and control
Wireless communication is routinely used for data links in SCS systems to allow physicians and patients to program the settings of the implanted device; operational characteristics are available from the various manufacturers.
29-31
Recent examples of research-grade versions of bi-directional Gentle inward pressure causes slight inward "dimpling" of the pial surface by the electrode. As a result, the un-insulated (active) exposed surface of the electrode is "sealed" by spinal cord tissue enveloping the protruding portion of the contact. A small gap separates the electrically inactive portions of the I-Patch device, providing space into which the spinal cord tissue may expand and contract with cardiac pulsation cycles.
044702-4
telemetry controllers for spinal cord stimulators 32 and neuroprostheses 33 report power consumptions of 200 and 420 mW, respectively. The former works in the 2.0-13.56 MHz range, and the latter at a data rate of 500 kb s
À1
. The implicit assumption underlying all existing SCS systems is that in spite of long battery lifetimes during normal use (e.g., 5 to 10 yr), surgical access to the implant for the purpose of changing the battery will be possible and expected. However, because of the intra-dural location, the I-Patch device is fundamentally different in that regard: there is virtually no space available for an on-board battery and, even if there were, the risks of surgical access to change it would be prohibitive. Therefore, the design necessarily involves inductive power coupling and the need to minimize the on-board dissipation. In turn, those requirements dictate that as much of the processing and control electronics as possible be located in the transmitter module, and that only those functions needed to actually select and activate given electrodes be included on the I-Patch itself. They further suggest that a useful overall strategy would be one in which the I-Patch was not activated (and thus not dissipating any power) in between the individual therapy pulses. With the computational and processing overhead removed from the IPatch, the "on-cycle" power requirements associated only with electrode selection and activation should drop to (5 mW. We note that this is a very liberal upper limit on the power requirement. The functional complexity envisioned in the wireless receiver circuit discussed in Sec. III B 2 below will require less than 10 3 logic gates and, at < 10 nW per CMOS gate, 34 the resulting circuit dissipation would be < 1 lW. (Other wireless data links for biomedical implants 35 operate at somewhat larger powers, approximately 100 lW.) However, to provide for the possibility of supporting extra signal processing functionalities in subsequent designs, and especially to insure the delivery of adequate current densities within the target tissues, we allow for the milliwatt-level power transfer capability. We note that this is similar to the consumption of the stimulator stage of the implantable device reported by Sacristán-Riquelme and Osés 36 (approximately 4 mW). Moreover, it is within the paresthesia threshold range reported for both amplitude-voltage mode and amplitude-current mode use of a commercially available stimulator employed in a recent human clinical trial. 37 From the means and standard deviations reported for the amplitude-currents and the resulting calculated voltages in that trial, we note that the paresthesia-threshold stimulation power range was 1.1 to 46.1 mW. However, typical use of such devices tends to be at low voltages, and therefore at the lower-power end of that range (e.g., in their randomized prospective study, North et al. 38 found that an insulatedarray permanent electrode device performed very well in patients at just 1.4 V).
In terms of operating frequency, the U.S. Federal Communications Commission permits "industrial, scientific, and medical (ISM)" equipment to operate at any frequency above 9 kHz with the exception of certain safety, search and rescue frequency bands. 39 Moreover, there are bands associated with physiological rf windows that are specially allocated for ISM equipment at (6.780 6 0.015), (13.560 6 0.007), (27.120 6 0.163) and (40.680 6 0.020) MHz. While these dedicated bands are somewhat fast for simple logic switching, the body's transparency at them would help to minimize losses. In any case, the I-Patch system must be designed to minimize the possibility of crosstalk or interference with any other wireless devices, e.g., RFID tags, etc. Taking all of this into account, it is most likely that the chosen frequency will be between 1.0 and 10 MHz, with the lower bound dictated by the need for sufficient bandwidth to accommodate the pulse coding and decoding requirements of the circuit described in the next section.
A circuit design that addresses these issues is presented in the next section. We also provide the preliminary data from a feasibility study of the power-and signal-transfer parts of the circuit that was carried out over a wireless coupling between components of actual I-Patch scale.
III. MATERIALS, METHODS, AND PRELIMINARY RESULTS
We fabricated several engineering-grade prototypes of pliable substrates scaled to suitable I-Patch dimensions, and installed surface-mounted microcoils on them to serve as suitable primary and secondary windings in transformerbased studies of the wireless coupling mechanism envisioned for use. In parallel with that effort, we have also begun the process of modeling the current density distributions in the target tissues, as a function of location of the stimulating electrodes. Although both efforts are still in a very early stage relative to the final needs of the project, the results obtained to date point the way toward the improvements needed to arrive at a clinically viable implant, and hence we present them below. 
A. Estimating current densities
In Fig. 4 , some aspects of the present paradigm of SCS function are depicted. For instance, the placement of the electrode contacts on the outer surface of the dura surrounding the spinal cord will result in most of the stimulus current being shunted through the CSF because of its high conductivity. One consequence of this is activation of non-targeted dorsal nerve rootlets, which can lead to patient discomfort. Another is that there will thus be minimal activation of the sub-pial pathways which are the actual targets. Because of the complex anatomy and anisotropic conductivities of the tissues in this region of the body, computational modeling, and in particular, finite element modeling (FEM) is needed to arrive at quantitative estimates of the relevant current density distributions. Several of the early papers on FEM models of epidural stimulation of the spinal cord were written by Coburn and colleagues [40] [41] [42] [43] and also by Holsheimer and colleagues, [44] [45] [46] [47] who developed the University of Twente's Spinal Cord Stimulation Software Package which has been applied extensively to investigate this treatment modality.
11,21,48,49
Using Holsheimer's estimates for the relevant tissue conductivities, 21 we have carried out some elementary FEM simulations of current patterns that might be produced by the I-Patch system in the spinal cord, and by standard SCS electrodes placed on the surface of the dura. For simplicity, this preliminary work has been done with a two-dimensional COMSOL TM model (based on Poisson's equation) in which all structures are taken to be very long in the vertical direction to minimize any end effects. We have likewise assumed that the conductivities are homogenous and isotropic for vertebral bone, epidural fat, CSF, and white and gray matter. Figure 5 shows an example of the current distribution within a cross-section of the spinal cord and the surrounding CSF for the case where two metallic electrodes have been placed just inside the pial surface of the white matter, thus modeling the direct spinal cord stimulation that will be achieved with the I-Patch. The electrodes are approximated by the small circles shown in the simulation, and have been charged to a potential difference of 2 V. As shown in the figure, because of the high conductance of the cerebrospinal fluid, the current density in the CSF is still about three times that of the white matter and twice that of the gray, except in the immediate sub-pial vicinity of the electrodes. Even though the model is very simple in nature, this result confirms the need expressed in our design objectives to optimize the configuration, electrical characteristics, and means of attachment of the electrodes to the spinal cord surface in order to minimize coupling to the CSF while maximizing the coupling to the target tissue zones.
Of course, one can also use the FEM approach to explore how the current density inside the spinal cord depends on the placement of the electrodes. In Fig. 6 , two very different cases are simulated. Case A shows the current distribution in the spinal cord resulting from placement of two electrodes on the dural membrane, just inside the epidural fat layer (similar to present modes of SCS), while case B shows the distribution due to electrodes just inside the 
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Howard III et al. J. Appl. Phys. 110, 044702 (2011) surface of the spinal cord white matter (similar to the I-Patch approach). The potential difference has again been kept at 2 V in each case. The main conclusion again is that duralbased stimulation is associated with shunting of current by CSF resulting in spatially diffuse, low-intensity penetration of the spinal cord white matter, whereas direct spinal cord stimulation achieves a sharply contoured, high-intensity projection of current extending beneath the spinal cord surface. While valuable, these preliminary simulations suffer from many limitations. For instance, the values of the conductivities used may represent oversimplifications, and the anisotropies within different regions of the spinal cord must be taken into account. In particular, the conductivity of the white matter is known to be substantially larger in the axial direction than it is in the transverse directions. Because precise quantitative predictions will be needed to inform the IPatch design process, true three-dimensional models that take into account all tissue geometries, etc. must be formulated, and we are presently in the process of carrying out that work.
B. Power and signal coupling: circuit designs and feasibility tests
Silicone I-Patch blanks and antennae windings
To begin the process of evaluating the feasibility of our proposed approach to spinal cord stimulation, we made an early prototype version of an I-Patch device that could be used to investigate the wireless communication and power transfer requirements of the system. The substrates were of polyorganosiloxane compound that was poured in an ovalshaped mold 1 mm deep, 13 mm wide, and 24 mm long, with a pair of opposing 10 mm arms extending medially from either side. The total surface area of each resulting soft blank (excluding the arms) was estimated to be 260 mm 2 . A pair of rf antenna coils was surface-mounted on each blank. The coils were approximately 9 mm in diameter and consisted of 25 turns of No. 45 wire each, for a resistance of 8.9 X and an inductance of 68 lH. By placing one such assembly directly on top of another, we could effectively create a transformer with a 1:1 turns ratio and a nominal gap of 1 mm between the coils (i.e., the thickness of one blank). A photo of these assemblies is provided in Fig. 7 , which shows a pair of I-Patch blanks (with coils) placed side-by-side on the manifold to which the leads of each coil were connected. The connections were made by stripping the insulation from the last 1 cm of each lead and then clamping them securely by nut and bolt between a pair of washers. The upper part of the bolt then served as a binding post for making robust connections to the remaining circuitry.
In this arrangement, the coils on one of the I-Patch blanks could serve as the signal transmitter while those on the other blank served as the receiver. The dimensions of the coils and substrates were chosen to approximate the size of a clinically useful device. The reason for placing two coils on each blank was to take advantage of the intrinsic commonmode rejection offered by summing the signals from counter-wound (quadrupole) pairs of the coils, thus potentially reducing the effects of electromagnetic background noise and interference. We recognize, though, that the axial movements of the spinal cord relative to the (fixed) transmitter implant may be large enough to offset the alignment of opposing transmitter/receiver coil pairs such that the signal strength of the coupling becomes too weak. That situation will likely necessitate the requirement for a single pair of opposing transmitter/receiver coils that are scaled to maintain sufficient flux coupling even in conditions of only fractional overlap of opposing coil areas. Even so, we opted to investigate the more general quadrupole case first, hence the arrangement shown in Fig. 7 . 
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2. Implant circuit There are two guiding principles behind the design envisioned for the I-Patch circuit. The first is that of maximizing the reliability of the spinal cord implant itself by minimizing the number of functions it must perform and, therefore, its complexity and the power needed to carry them out. In practice, this means that all of the system's computational and memory components must be resident in the transmitter unit, which is positioned in the extradural space where larger implant volumes are well tolerated. Second, our concept is to communicate and initiate separately each therapeutic pulse delivered by the I-Patch. The signal transmitted to it will power up the I-patch, convey the index number of the electrode pair to be activated and, finally, the pulse shape (duration and intensity). This is followed by a pause during which the I-patch implant powers down, to be reactivated at the next cycle which, depending on the therapy protocol, may activate a different electrode, or electrode combination. Total cycle time will be on the order of 10-20 ms. The intent is thus for the implant's circuit to be normally off unless activated by the signals transmitted by the extradural device.
A circuit that, in principle, is able to meet these goals is shown in Fig. 8 . The system's controller and epidural transmitting coil are shown in the upper part of the illustration, and the devices resident on the I-Patch, including the intradural receiver coil, are shown in the lower part of the figure. The signal transduced by the intradural coil does three things. First, it constitutes the raw ac input that must be demodulated to extract the pulse sequencing information. Second, it is then rectified to produce the power for the downstream pulse-control part of the circuit. Lastly, it is the source of the circuit reset pulse that is used to re-initiate the electronics after each successfully decoded electrode pulsing cycle. In this arrangement, a phase-locked loop (PLL) demodulates the carrier and drives a binary counter that tallies the number of phase transitions, which constitutes the control signal that had been encoded in the carrier. Then, three data lines that convey an 8-bit number form the output of the counter, which is then decoded to drive one of 8 output lines, each of which energizes a particular electrode. The decoder's output lines are gated open by a monostable multivibrator that is latched "on" during the data delivery period following receipt of a reset signal. All of these functionalities must be powered by and reset from the rectifier/Schmitt trigger arrangement, the capacitors of which store the energy that the remainder of the circuit utilizes during each data delivery and pulsing cycle. The timing diagram for all of the relevant events is shown in Fig. 9 .
For the actual I-Patch device, thin-film versions of the circuit will be microfabricated and integrated onto the mounting substrate for clinical use. However, for our preliminary tests of the concepts underlying the circuit design, we built prototypes of it from discrete components and carried out several feasibility studies. Among them was an investigation of what are perhaps the central technical issues associated with the wireless coupling: the ability to transmit, receive, and demodulate an arbitrary control waveform 
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Howard 2011) embedded in a carrier, and the ability to transmit and recover sufficient power to operate the circuit. These functions are both intrinsically analog within the nature of our design.
Therefore, in what follows, we focus on only that part of the circuit which handles those tasks, and defer further description of the standard digital counting, decoding and gating functions.
Circuit performance characteristics
To evaluate the wireless communications capabilities of the I-Patch system, we used a test arrangement that employed the voltage-controlled oscillator (VCO) of a CD4046B PLL chip 50 as the transmitter, the I-Patch coils shown in Fig. 7 as the emitter and receiver antennae, and a second identical PLL as the output demodulator. For the passive tuning components that were chosen, the VCO calibration curve is shown in Fig. 10 . A linear fit for VCO frequency, f (in kHz) versus dc control voltage, V, yields f ¼ 181.8V þ 1484.4 (R 2 ¼ 0.9866) for operation at rail voltages of 6 5 Vdc. For the frequency modulation tests, the ac input voltage signal for the VCO was produced by a BK Precision V R 4012 A function generator, the 10 kHz, 1 V p-p waveforms from which were offset to swing between 0 and þ 1 V. A modulation frequency of 10 kHz was used because (10 kHz) À1 ¼ 100 ls is a nominal value for the pulse width often employed in clinical SCS systems. The resulting frequencymodulated VCO output signal, which was 2.5 V p-p and centered on approximately 1.6 MHz, drove the transmitter antenna (Fig. 7, coils 1 and 2 connected in series) . The IPatch receiver antenna (Fig. 7 , coils 3 and 4 connected in series) was positioned immediately underneath the respective transmitter coils, with a 1 mm separation due to the thickness of the silicone mounting blank. The resulting primary/secondary transformer configuration wirelessly coupled the signal into the receiver PLL at a strength of about 2 V p-p , and the original modulation signal could then be recovered at the PLL's demodulator output. Figure 11 shows an example of the circuit's operation for the case of a triangular waveform. The upper trace of the oscilloscope photo shows the input signal driving the transmitter VCO, and the lower trace shows the PLL's demodulated output signal following wireless coupling through the I-Patch antenna coils. Similar results were obtained with all other waveforms that were tested, including sine waves, square waves and pulse trains. 
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In a preliminary evaluation of the wireless coupling's power transmission capabilities, we employed a full-wave rectifier consisting of four Schottky diodes, 1N5711 and, as a load, a LED display lamp with a current-limiting resistor of approximately 500 X. When driving the I-Patch receiver antenna as described above, the rectifier output of 1 to 2 Vdc (which depended on the degree of overlap of the antenna/ transformer coils) was sufficient to cause the LED to glow. While this indicated that the wireless power-supply function of the circuit was able to generate an estimated 5mW on the receiver side, further work is clearly needed to optimize the flux coupling in the transformer, determine the power consumption on the primary side, and minimize any ripple and drift on the receiver side.
IV. DISCUSSION
A. Overall considerations
As a wireless neuroprosthesis, the I-Patch differs markedly from virtually all other such devices. That it must be placed and reside indefinitely on the surface of the spinal cord itself is the chief differentiating factor, and this dictates a wireless coupling between the afferent and efferent components of the system, as well as battery-free operation, low power dissipation, and the highest level of reliability for the implant itself. Our work to date on this system has focused on establishing quantitative design requirements, making numerical estimates of the therapeutic levels of current density that can be delivered into the spinal cord, and testing critical performance features of preliminary versions of the implant circuitry.
At this point, we have demonstrated the workability of a key aspect of the I-Patch circuit, viz., the transmission and reception of pulse-encoding information via wireless coupling between antennae coils of proper scale mounted on silicone substrates of anatomical dimension suitable for this unique clinical application. We have also demonstrated that the same transmitted ac signal can be rectified to produce power levels that are in the working range needed to operate the electronics on-board the implant. While these are encouraging steps forward, there is much left to do before a device with functionalities suitable for in vivo testing is available.
For instance, in these proof-of-principle studies the coils were not yet optimized in terms of either their mechanical or electrical parameters. From the mechanical perspective, because the layer of CSF separating the pial surface of the spinal cord from the inner wall of the dura is very thin, the coils (and for that matter all of the I-Patch) must have a very low profile. This calls for micro-fabricating the coils as a layer on a thin-film surface, with the number of turns and winding dimensions within that layer optimized to take full advantage of the available surface area. Our laboratories routinely undertake this type of design task to develop microcoils for magnetic resonance applications in microfluidics, 51 and we are moving forward accordingly.
From the electrical perspective, another part of that optimization process seeks to maximize the inter-coil power transfer, which is not constant because the I-Patch moves with the spinal cord relative to the fixed epidural transmitter coil whenever the patient bends or otherwise changes position. The resulting lateral and angular offsets between the coil axes changes the area of overlap between the coils and, therefore, the mutual inductance between them. This, in turn, will decrease the power in the received signal. However, the effects of these types of misalignment of rf coil pairs as used for inductive power transfer in implantable medical devices have been studied extensively by many authors [52] [53] [54] [55] [56] [57] [58] [59] including cases similar to ours in scale and geometry of the coils. 60, 61 Lateral offset of the axes of planar coils is most relevant here, and of the similar cases, Soma et al. 60 in particular found that for two identical planar coils that are initially coaxial and spaced 5 mm apart, the mutual inductance rolls off by roughly 6% per mm of subsequent offset of the axes. Given these available studies, we deferred the detailed assessment of mutual inductance roll-off (and hence, of decrease in efficiency of power transfer) for our preliminary system until such time as prototypes of the microfabricated coils mentioned above are available. However, we did develop protocols for carefully mapping the magnetic fields of such micro-coils in preparation for measuring any field inhomogeneities that might also contribute to mutual inductance (and therefore power transfer) variations.
B. Work in progress
Device configuration
In terms of establishing workability of the electronic design, our next steps will include (a) bench-top incorporation of the digital counting, decoding and electrode selection components of the circuit, (b) optimization of the transmitter and receiver antennae designs, and (c) thorough confirmation that the wireless coupling can produce enough power to reliably operate the fully assembled prototype of the device. At that point, we will miniaturize the circuit to create a thinfilm electronics version that can reside on a biocompatible substrate made of parylene, PDMS or another suitable material. 28 In addition to serving as a flexible housing for the receiver coil, circuit, and electrode array, the resulting device will also need to have mechanical properties that enable it to conform precisely to the external contour of the spinal cord and achieve optimal contact between each electrode and the pial surface. For eventual clinical application, this will likely require that the I-Patch be pre-formed to the surface contour of the individual patient's spinal cord, as determined by preoperative imaging, thus possibly requiring a shape-memory polymer component in the construction of the device.
However, that structural arrangement also gives rise to an additional basic mechanical issue we are investigating. As discussed in Sec. II C, the small, cyclical expansion and contraction ("breathing mode") of the spinal cord may lead to sliding of the electrodes on the pial surface if the implant is only flexible in bending, but extensionally rigid. The magnitude of the sliding displacement would be of the same absolute order as the radial movement. Since the latter is on the order of 100 lm, the electrode contact points would move by approximately the same amount. Since the I-patch is held in place by exerting a small amount of radial pressure, its structure must be somewhat stiff in bending. On the other hand, to accommodate the pulsation, it must at the same time be compliant in extension in order to avoid a residual (but presumably non-negligible) skidding of the electrodes on the pial surface. If there is risk of inflammation due to such an effect, then this mechanical conflict may require that the arms be either zig-zag in shape with planar hinge points at the corners, or that the electrodes be positioned in islands of softer material located along the length of the arms.
Performance and testing targets
We have drawn on our long-standing interests in the design, testing and implementation of electrode implants for neural recording and stimulus in animal models and patients [62] [63] [64] [65] [66] to develop a protocol that should be useful for the in vivo testing of the prototype I-Patch, once the microfabrication of it has been carried out. This plan calls for the use of an ovine model, because the size and morphology of the spinal cord in sheep, Fig. 12(a) , has useful similarities to that in humans, Fig. 12(b) . Testing will include chronic survival studies designed to detect any long term adverse effects of the I-Patch on spinal cord tissue, such as inflammatory changes, syrinx formation, etc. We will also investigate whether or not placing this type of electrode grid on the pial surface causes any reactions that might lead to either gliosis or fibrotic adhesions which could alter the stimulation thresholds over time. Repeated neurophysiological and gait analysis studies will also be performed to detect possible deleterious effects on normal spinal cord function. These experiments will provide critical information about the nature of I-Patch electrode contact-tissue coupling and the ability of the device to physiologically activate spinal cord motor and sensory pathways, as measured using somatosensory and motor-evoked potential methods. All of these preclinical safety and neurophysiological efficacy studies will be carried out with the ultimate goal of safely transitioning into a "first-in-man" pilot clinical trial.
V. CONCLUSIONS
We have conceived a new electrical stimulation device to be implanted directly on the spinal cord for the treatment of intractable pain. This device differs markedly from existing spinal cord stimulators and is designed to overcome the most important fundamental limitation of the systems currently in use: an inability to selectively deliver highly focused stimuli to circumscribed regions of the spinal cord. In this paper we have explored the biophysical design criteria that underlie its form and function. This device relies on a wireless coupling of power and control signals between it and a computational host device that is also implanted, but in the epidural region outside of the spinal canal. In preliminary tests of a communications technique specific to the dimensions and configuration of this device, we were able to successfully transmit and receive control signals, the frequencies and amplitudes of which are commensurate with those employed in standard spinal cord stimulators in clinical use today. Plans for building on this result and moving forward toward completion of a prototype suitable for in vivo testing are presented and discussed. 
